Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

First superannuation lecture delivered at the UFS
2009-11-18

Proff. Voet du Plessis (left) and Johan Henning, Dean of the Faculty of Law.
Photo: Stephen Collett


Prof. Voet du Plessis from the Department of Mercantile Law in the Faculty of Law at the University of the Free State (UFS) recently presented the first superannuation lecture at the UFS.

Prof. Du Plessis retired this year after 41 years at the UFS. This milestone event coincides with the faculty’s celebration of a century of excellence in legal education under the theme “Iurisprudentia 100”.

With his superannuation lecture Prof. du Plessis gave a view on the future of worker participation in enterprises. Thirty years ago during his inaugural lecture he discussed a similar topic: Worker participation in the management organs of a company.

According to him there is currently no worker participation in management organs in South African companies. The South African legislation does give extended abilities and protection for workers. In spite of this protection South African legislation falls short with regard to a possible say workers may have in or influence that workers may exercise over decisions taken in the workplace and which affect them as workers directly.

In terms of the right to information and consultation he gave the following suggestions to improve the current system of worker participation in decisions which affect them as workers:

“Serious attention must be given to the changes to the current Labour Relations Act, 1995 for the compulsory establishment of a workplace forum in each workplace with 50 or more workers, to oblige the employer to take the initiative with the establishment of a workplace forum; and to give to registered trade unions who are recognised in the workplace the sole right to nominate candidates for the workplace forum,” said Prof. du Plessis. He also proposed that attention be given to a Southern African Work Committee. An increase in world wide economic operations through multi national companies with head quarters abroad where decisions about the misfortunes of workers in the Southern African region are taken makes such a decision essential.
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept